Context Therapeutics

Context Therapeutics is a clinical-stage biotechnology company dedicated to developing the next generation of therapies to treat solid tumors. Their focus is on developing T cell engaging bispecific therapeutics, which are designed to target specific proteins on cancer cells and activate the body's immune system to destroy them. Their current pipeline includes two lead candidates, CTIM-76 and CT-95, both of which are being investigated in clinical trials. CTIM-76 targets the Claudin 6 protein, which is overexpressed in various cancers, including ovarian, endometrial, testicular, and gastric cancer. CT-95 targets mesothelin, another protein that is often found on cancer cells, including mesothelioma, ovarian cancer, and pancreatic adenocarcinoma.

Context Therapeutics is committed to providing patients with access to their investigational therapies, both through clinical trials and through their Expanded Access Program. They also support the scientific community by providing funding opportunities for investigator-initiated trials that align with their therapeutic areas of interest. The company believes their innovative approach to immunotherapy has the potential to significantly improve treatment outcomes for patients with solid tumors.

Context Therapeutics is a biotechnology company dedicated to developing the next generation of therapies to treat solid tumors. Their mission is driven by a passion for improving health outcomes for cancer patients, believing it is possible to find better treatments for them and their families. This commitment is reflected in their innovative portfolio of clinical-stage T cell engaging bispecific therapeutics, including CTIM-76 and CT-95, which are designed to target specific tumor-associated antigens while minimizing harm to healthy tissues.

Context Therapeutics promotes a culture centered around collaboration, innovation, and patient-centricity. They are united by their passion for helping cancer patients and believe in working together to find solutions. The company emphasizes transparency, accountability, and inclusion, creating a supportive and engaging environment where employees are encouraged to contribute and learn from one another.

Context Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace. They strive to create an environment where all employees feel valued, respected, and empowered to contribute their unique perspectives and talents. The company acknowledges the importance of representation at all levels and actively seeks to recruit, develop, and retain a diverse workforce. Their commitment extends beyond their employees, as they are dedicated to ensuring their products and services are accessible and equitable for all patients.